Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterNo recent work listed

John E. Mullinax

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9596-6785; OpenAlex author ID A5039971014. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper

Papers 3

  1. Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells. First author DOI 10.1186/s12885-018-4690-1↗
  2. Robotic Whipple Procedure for Pancreatic Cancer: The Moffitt Cancer Center Pathway. First author DOI 10.1177/107327481502200313↗
  3. Survival after pancreatectomy for pancreatic adenocarcinoma is not impacted by performance status. Co-author DOI 10.1016/j.amjsurg.2012.01.016↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Itzhak Avital · 1 shared paper, 2018 · strength 0.08
  2. Dandan Li · 1 shared paper, 2018 · strength 0.08
  3. Udo Rudloff · 1 shared paper, 2018 · strength 0.08
  4. José M. Pimiento · 1 shared paper, 2015 · strength 0.06
  5. Omar Maen Rashid · 1 shared paper, 2015 · strength 0.06
  6. Mokenge Peter Malafa · 1 shared paper, 2015 · strength 0.06
  7. Kenneth Lee Meredith · 1 shared paper, 2015 · strength 0.06
  8. Paul G. Toomey · 1 shared paper, 2012 · strength 0.03
  9. Jonathan Matthew Hernandez · 1 shared paper, 2012 · strength 0.03
  10. Alexander S. Rosemurgy · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.